ACP6

acid phosphatase 6, lysophosphatidic, the group of Acid phosphatases

Basic information

Region (hg38): 1:147629652-147670524

Links

ENSG00000162836NCBI:51205OMIM:611471HGNC:29609Uniprot:Q9NPH0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ACP6 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACP6 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
1
clinvar
23
clinvar
4
clinvar
2
clinvar
30
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 1 23 4 3

Variants in ACP6

This is a list of pathogenic ClinVar variants found in the ACP6 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-147647445-A-G not specified Uncertain significance (May 16, 2022)2289892
1-147647504-C-T not specified Uncertain significance (Apr 17, 2023)2537350
1-147647506-T-C Benign (Nov 20, 2018)711973
1-147648251-C-T not specified Uncertain significance (Oct 25, 2023)3139059
1-147648270-A-T not specified Uncertain significance (Feb 23, 2023)2488290
1-147648276-C-A not specified Uncertain significance (Aug 12, 2021)2243973
1-147650153-C-T not specified Likely benign (Mar 07, 2023)2495199
1-147652546-G-A not specified Uncertain significance (May 30, 2024)3262499
1-147654205-C-T not specified Uncertain significance (Jun 05, 2023)2516475
1-147654208-C-T not specified Likely benign (Oct 26, 2022)2320924
1-147654241-C-T not specified Uncertain significance (Aug 08, 2022)2306138
1-147654262-T-C not specified Likely benign (Sep 26, 2022)2313179
1-147654301-G-C not specified Uncertain significance (Oct 29, 2021)3139114
1-147654302-T-C Benign (Nov 20, 2018)783945
1-147654314-C-G not specified Uncertain significance (Jul 20, 2021)2238828
1-147654322-G-A not specified Benign (Mar 06, 2015)218733
1-147655173-C-T not specified Uncertain significance (Aug 09, 2021)2241477
1-147655201-G-A not specified Uncertain significance (Oct 30, 2023)3139101
1-147655209-A-C not specified Uncertain significance (Nov 27, 2023)3139098
1-147655223-T-G not specified Uncertain significance (Mar 20, 2023)2546967
1-147659017-G-A not specified Uncertain significance (Aug 16, 2021)2245658
1-147659415-A-T not specified Uncertain significance (Oct 25, 2022)2393762
1-147659456-C-T not specified Uncertain significance (Apr 08, 2024)3262488
1-147659466-C-T not specified Uncertain significance (Dec 17, 2021)2267834
1-147659496-C-T Cerebral visual impairment and intellectual disability Likely pathogenic (Sep 09, 2015)224824

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ACP6protein_codingprotein_codingENST00000369238 1041166
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.33e-130.03471256820661257480.000262
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6782062350.8760.00001172791
Missense in Polyphen5150.8691.0026537
Synonymous0.7848796.80.8990.00000525816
Loss of Function0.1932021.00.9558.92e-7249

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005520.000536
Ashkenazi Jewish0.000.00
East Asian0.0007110.000707
Finnish0.00004620.0000462
European (Non-Finnish)0.0001870.000185
Middle Eastern0.0007110.000707
South Asian0.0004910.000490
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. {ECO:0000269|PubMed:10506173, ECO:0000269|PubMed:23807634}.;
Pathway
Vitamin B2 (riboflavin) metabolism;Metabolism of lipids;Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PA (Consensus)

Recessive Scores

pRec
0.232

Intolerance Scores

loftool
0.822
rvis_EVS
0.86
rvis_percentile_EVS
88.74

Haploinsufficiency Scores

pHI
0.101
hipred
N
hipred_score
0.170
ghis
0.495

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.594

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Acp6
Phenotype
normal phenotype;

Gene ontology

Biological process
hematopoietic progenitor cell differentiation;phospholipid metabolic process;phosphatidic acid biosynthetic process;dephosphorylation;lysobisphosphatidic acid metabolic process
Cellular component
cytoplasm;mitochondrion;mitochondrial matrix
Molecular function
acid phosphatase activity;lysophosphatidic acid phosphatase activity